The global foley catheters market was valued at USD 1.2 billion in 2021 and it is predicted to surpass around USD 2.17 billion by 2030 with a CAGR of 6.8% from 2022 to 2030.
Market Synopsis
Foley catheters also referred to as indwelling catheters, that can remain inside for a longer period. With the help of foley catheters, urine is collected in a drainage bag. These catheters are suitable for use in conditions like infections, enlarged prostate, urinary incontinence, urinary retention, and bladder stones. Based on the route of entry, foley catheters are categorized into urethral and suprapubic catheters. Urethral catheters are inserted in the bladder through the urethra. Suprapubic catheters are inserted into the bladder through a small cut in the abdomen above the pubic bone. These catheters are used for long-term bladder management.
Scope of The Report
Report Coverage | Details |
Market Size in 2021 | USD 1.2 billion |
Revenue Forecast by 2030 | USD 2.17 billion |
Growth rate from 2022 to 2030 | CAGR of 6.8% |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segmentation | Product Type, Material, Indication, End-user, Region |
Companies Covered |
Teleflex Incorporated, Cardinal Health, Angiplast Private Limited, Medtronic, Convatec Inc., B. Braun Melsungen AG, VOGT MEDICAL, Sterimed Group, Ribbel International Limited, C. R. Bard, Coloplast Corp., among others |
Market Influencer
The increasing prevalence of urological disorders, such as urinary retention, cystitis, benign prostatic hyperplasia, urinary incontinence, and kidney stones, which can lead to bladder dysfunction are some of the major factors anticipated to drive the foley catheters market growth globally. For instance, according to the Urology Foundation in 2021, urinary incontinence affects 5% of all men and 13% of women at some stage in their lives. Estimated 3 - 6 million people in the UK have urinary incontinence. Moreover, rising demand for antimicrobial catheters along with increasing demand for home care services are the other factors which are increasing the growth of foley catheters market.
Another factor has a positive impact on market growth is the outbreak of COVID-19 , starting in the year 2020. For instance, according to NCBI, indwelling urinary catheter usage increased during the initial pandemic period by 36%. Moreover, hospitalized COVID-19 patients have a higher incidence of Central Line-associated Blood Stream Infections (CLABSI) and Catheter-associated Urinary Tract Infections (CAUTI). Therefore, the COVID-19 pandemic has brought attention to the critical need for infection prevention. As a result, several manufacturers are able to offer products such as urine coated catheters with temperature monitoring to ICU patients as stronger protection against secondary infections, which is expected to boost the market growth. For instance, in February 2021, Health Canada approved urine Bactiguard's catheter with a temperature sensor for infection prevention. COVID-19 sped up the approval process because Bactiguard's urinary catheters can lower the incidence of secondary infections in critically ill patients, boosting the market growth.
Furthermore, companies operating in the market are introducing additional features in foley catheters to address the growing issues pertaining to their use, such as curtailing the risks of infections and maintaining an adequate flow rate. Thus, the abovementioned factors are likely to drive the catheters market during the forecast period. For instance,
These technological advancements are expected to boost the foley catheters market growth in the forecast period. However, growing concerns regarding Catheter-Associated Urinary Tract Infection (CAUTI) and availability of alternatives are expected to obstruct the market growth.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Foley Catheters Market
5.1. COVID-19 Landscape: Foley Catheters Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Foley Catheters Market, By Product
8.1. Foley Catheters Market, by Product, 2022-2030
8.1.1. 2 Way
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. 3 Way
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. 4 Way
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Foley Catheters Market, By Material
9.1. Foley Catheters Market, by Material, 2022-2030
9.1.1. Latex Foley Catheter
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Silicon Foley Catheter
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Foley Catheters Market, By Indication
10.1. Foley Catheters Market, by Indication, 2022-2030
10.1.1. Urinary Incontinence
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Urethral Stricture
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Chronic Obstruction
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Neurogenic Bladder
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Enlarged Prostate Gland/BPH
10.1.5.1. Market Revenue and Forecast (2017-2030)
10.1.6. Prostate Cancer
10.1.6.1. Market Revenue and Forecast (2017-2030)
10.1.7. Others
10.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Foley Catheters Market, By End-user
11.1. Foley Catheters Market, by End-user, 2022-2030
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Long Term Care Facilities
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Others
11.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Foley Catheters Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.2. Market Revenue and Forecast, by Material (2017-2030)
12.1.3. Market Revenue and Forecast, by Indication (2017-2030)
12.1.4. Market Revenue and Forecast, by End-user (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Material (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Indication (2017-2030)
12.1.5.4. Market Revenue and Forecast, by End-user (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Material (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Indication (2017-2030)
12.1.6.4. Market Revenue and Forecast, by End-user (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.2. Market Revenue and Forecast, by Material (2017-2030)
12.2.3. Market Revenue and Forecast, by Indication (2017-2030)
12.2.4. Market Revenue and Forecast, by End-user (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Material (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Indication (2017-2030)
12.2.5.4. Market Revenue and Forecast, by End-user (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Material (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Indication (2017-2030)
12.2.6.4. Market Revenue and Forecast, by End-user (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Material (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Indication (2017-2030)
12.2.7.4. Market Revenue and Forecast, by End-user (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Material (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Indication (2017-2030)
12.2.8.4. Market Revenue and Forecast, by End-user (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.2. Market Revenue and Forecast, by Material (2017-2030)
12.3.3. Market Revenue and Forecast, by Indication (2017-2030)
12.3.4. Market Revenue and Forecast, by End-user (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Material (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Indication (2017-2030)
12.3.5.4. Market Revenue and Forecast, by End-user (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Material (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Indication (2017-2030)
12.3.6.4. Market Revenue and Forecast, by End-user (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Material (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Indication (2017-2030)
12.3.7.4. Market Revenue and Forecast, by End-user (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Material (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Indication (2017-2030)
12.3.8.4. Market Revenue and Forecast, by End-user (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.2. Market Revenue and Forecast, by Material (2017-2030)
12.4.3. Market Revenue and Forecast, by Indication (2017-2030)
12.4.4. Market Revenue and Forecast, by End-user (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Material (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Indication (2017-2030)
12.4.5.4. Market Revenue and Forecast, by End-user (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Material (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Indication (2017-2030)
12.4.6.4. Market Revenue and Forecast, by End-user (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Material (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Indication (2017-2030)
12.4.7.4. Market Revenue and Forecast, by End-user (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Material (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Indication (2017-2030)
12.4.8.4. Market Revenue and Forecast, by End-user (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.2. Market Revenue and Forecast, by Material (2017-2030)
12.5.3. Market Revenue and Forecast, by Indication (2017-2030)
12.5.4. Market Revenue and Forecast, by End-user (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Material (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Indication (2017-2030)
12.5.5.4. Market Revenue and Forecast, by End-user (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Material (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Indication (2017-2030)
12.5.6.4. Market Revenue and Forecast, by End-user (2017-2030)
Chapter 13. Company Profiles
13.1. Teleflex Incorporated
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Cardinal Health
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Angiplast Private Limited
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Medtronic
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Convatec Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. B. Braun Melsungen AG
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. VOGT MEDICAL
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Sterimed Group
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Ribbel International Limited
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. C. R. Bard
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms